【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Hypercholesterolemia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Hypercholesterolemia to Metabolic Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Hypercholesterolemia to Metabolic Disorders Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Hypercholesterolemia 25
Subjects Recruited Over a Period of Time 32
Clinical Trials by Sponsor Type 33
Prominent Sponsors 34
Top Companies Participating in Hypercholesterolemia Therapeutics Clinical Trials 35
Prominent Drugs 37
Latest Clinical Trials News on Hypercholesterolemia 38
Apr 01, 2014: Sanofi and Regeneron Report Positive Results With Alirocumab From Phase 2 Japanese Study 38
Mar 30, 2014: Data From Phase 3 Pivotal Studies Show Amgen’s Novel Investigational Cholesterol-Lowering Medication Evolocumab Significantly Reduced LDL Cholesterol In Statin Intolerant Patients And In Patients On Statins 38
Mar 30, 2014: Evolocumab safely drops LDL cholesterol well below statin-only baseline 41
Mar 29, 2014: New Detailed Data from Three Phase 3 Pivotal Studies Show Amgen’s Novel Investigational Cholesterol-Lowering Medicine Evolocumab Significantly Reduced LDL Cholesterol By 55-66 Percent Compared To Placebo In Patients With High Cholesterol 42
Dec 19, 2013: Amgen Announces Positive Top-Line Results From 52-Week Phase 3 DESCARTES Study Of Evolocumab In Patients With High Cholesterol 44
Clinical Trial Profiles 46
Clinical Trial Overview of Top Companies 46
Merck & Co., Inc. 46
Clinical Trial Overview of Merck & Co., Inc. 46
AstraZeneca PLC 56
Clinical Trial Overview of AstraZeneca PLC 56
Sanofi 64
Clinical Trial Overview of Sanofi 64
Pfizer Inc. 69
Clinical Trial Overview of Pfizer Inc. 69
Regeneron Pharmaceuticals, Inc. 72
Clinical Trial Overview of Regeneron Pharmaceuticals, Inc. 72
Aegerion Pharmaceuticals, Inc. 75
Clinical Trial Overview of Aegerion Pharmaceuticals, Inc. 75
Novartis AG 77
Clinical Trial Overview of Novartis AG 77
Kowa Company, Ltd. 79
Clinical Trial Overview of Kowa Company, Ltd. 79
Isis Pharmaceuticals, Inc. 81
Clinical Trial Overview of Isis Pharmaceuticals, Inc. 81
Amgen Inc. 83
Clinical Trial Overview of Amgen Inc. 83
Clinical Trial Overview of Top Institutes / Government 85
National Heart, Lung, and Blood Institute 85
Clinical Trial Overview of National Heart, Lung, and Blood Institute 85
University of Manitoba 87
Clinical Trial Overview of University of Manitoba 87
Gachon University Gil Hospital 88
Clinical Trial Overview of Gachon University Gil Hospital 88
University of Pennsylvania 89
Clinical Trial Overview of University of Pennsylvania 89
University of Toronto 90
Clinical Trial Overview of University of Toronto 90
Osaka University 91
Clinical Trial Overview of Osaka University 91
University of Jena 92
Clinical Trial Overview of University of Jena 92
Maastricht University Medical Center 93
Clinical Trial Overview of Maastricht University Medical Center 93
Washington University School of Medicine 94
Clinical Trial Overview of Washington University School of Medicine 94
Monash University 95
Clinical Trial Overview of Monash University 95
Five Key Clinical Profiles 96
Appendix 200
Abbreviations 200
Definitions 200
Research Methodology 201
Secondary Research 201
About GlobalData 202
Contact Us 202
Disclaimer 202
Source 202
【レポート販売概要】
■ タイトル：高コレステロール血症（Hypercholesterolemia）：グローバル臨床試験レビュー（2014年上半期）■ 英文：Hypercholesterolemia Global Clinical Trials Review, H1, 2014
■ 発行日：2014年4月30日
■ 調査会社：GlobalData
■ 商品コード：GDHC2116CTIDB
■ 調査対象地域：グローバル
- 世界の中央静脈アクセス装置（Central Venous Access Devices）市場動向（2014～2018）TechNavio's analysts forecast the Global Central Venous Access Devices market to grow at a CAGR of 4.10 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing aging population. The Global Central Venous Access Devices market has also been witnessing the increased use of antimicrobial catheters. However, the high risk of vein thrombosis could …
- ビジネスジェットの世界市場2016-2020About Business Jets A business jet is an aircraft that is designed to transport small number of passengers. The travel prices for business jets are significantly higher than that of commercial airliners. These jets are usually owned and operated by corporations, individuals, government agencies, or commercial business jet operators that provide business jet charter services. Schemes such as Jet Ca …
- IOT（モノのインターネット）リーディング企業分析：オラクルThe world is moving beyond standalone devices into a new era in which everything is connected. The Internet of Things (IoT) refers to uniquely identifiable objects (things) and their virtual representations in an Internet-like structure. Stated differently, the concept involves the notion that there are many things (assets, objects, etc.) in the world that may be addressed/labeled/cataloged for va …
- Paramount Resources Ltd.：石油・ガスの開発・生産動向及びコスト分析- Q2, 2013Paramount Resources Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Paramount Resources Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential …
- ぶどう膜炎(Uveitis)：世界の治験レビュー（2015年上半期版）Uveitis Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Uveitis Global Clinical Trials Review, H1, 2015" provides an overview of Uveitis clinical trials scenario. This report provides top line data relating to the clinical trials on Uveitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Th …
- 血粉の世界市場展望2017-2026According to Stratistics MRC, the Global Blood Meal Market is accounted for $1.72 billion in 2017 and is expected to reach $2.49 billion by 2026 growing at a CAGR of 4.2% during the forecast period. Some of the key factors driving the market growth are growing demand for meat products in developing countries, increasing consumption of livestock products and rise in feed production. However, increa …
- 鍛造の世界市場2016-2020Technavio predicts the global forging market to exhibit a healthy CAGR of around 8% during the forecast period. Forging is an appropriate substitution to the casting methodology as it ensures greater efficiency, reliability, and precision. Custom forging accounts for the largest segment. In North America, this segment achieves sales figures worth $6 billion annually. Some of the major end-users of …
- 世界の患者介助用装置市場：車椅子、スクーター、医療用ベッド、バスルーム安全用品、機械装置、歩行補助具などThe global patient handling equipment market exhibits a lucrative growth potential for the next five years. The growth of this market is propelled by the rise in geriatric population and increasing lifestyle diseases such as diabetes and Cardiovascular Diseases (CVD) leading to increased disabilities. Further the market is driven by factors such as government policies promoting the use of patient …
- パーソナルケア製品用包装の世界市場2016-2026The global personal care packaging market is expected to reach $55.7bn in 2016 and develop dynamically over the forecast period, driven by emerging economies. Visiongain scrutinises the 10 leading national markets revealing where the business opportunities are: China, US, Japan, France, Russia, Germany, India, Brazil, the UK and Italy, as well as the rest of the world market. Furthermore, the pers …
- 世界における尿検査製品のパイプライン動向2015Urine Analysis - Pipeline Review, 2015 Summary GlobalData's Medical Devices sector report, “Urine Analysis - Pipeline Review, 2015" provides an overview of Urine Analysis products currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in …
- グローバルトップ15総合石油会社分析：生産量、財務、運用、コストなどTop 15 International Integrated Companies - Financial & Operational Fundamental Analysis and Benchmarking-2014 Summary Latest report from GlobalData "Top 15 International Integrated Companies - Financial & Operational Fundamental Analysis and Benchmarking-2014", the industry analysis specialists, that offers comprehensive information on the operational and financial performance of top 15 Internati …
- ビックデータ分野のリーディング企業分析：CSCBig Data represents a collection of data sets so large and complex that it becomes difficult to process using on-hand database management tool. It is also unstructured, meaning that it is not tabulated, correlated, etc. (e.g. it does not have a pre-defined data model or is not organized in a pre-defined manner). Big Data technologies enable organizations to handle huge datasets and generate inform …
- ハイドロゲルドレッシングの世界市場：製品別、地域別Global Hydrogel Dressings Market: About this market Technavio’s hydrogel dressings market analysis considers sales from amorphous hydrogel dressings, impregnated hydrogel dressings, and hydrogel sheet dressing products. Our study also finds the sales of hydrogel dressings in Asia, Europe, North America, and ROW. In 2019, the amorphous hydrogel dressings segment had a significant market share, and …
- 世界の商用ヘリコプタ市場動向2013-2023：市場のSWOT分析This SWOT analysis of Commercial Helicopter market is a crucial resource for industry executives and anyone looking to gain a better understanding of the market. SDI's "The Global Commercial Helicopter Market 2013-2023 - SWOT Analysis: Market Profile" report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. SDI st …
- 製薬産業向け濾過製品の世界市場：メンブレンフィルター、単回利用システム、限外濾過、クロスフロー濾過The global market is expected to USD 20,190.1 Million by 2020 from USD 12,451.3 Million in 2015, at a CAGR of 10.2% between 2015 and 2020. The major drivers for the market include the growth of biopharmaceutical industry, advancement in nanofiber technology, rapid expansion in generic drug production, increasing incidences of airborne disease, and strong biologics product pipeline. The emerging na …
